Shardul Amarchand Mangaldas & Co. Advised Underwriters On Niva Bupa Health Insurance Company’s IPO Shardul Amarchand Mangaldas & Co. (SAM & Co.) advised the Underwriters, viz., ICICI...
NCLT Hyderabad Rejects CIRP Petition Due To Operational Creditor's Non-Compliance With Section 69(2) Of The Indian Partnership Act In a significant ruling, the National Company Law Tribunal (NCLT)...
Supreme Court Clarifies Stakeholders Consultation Committee's Advice Not Binding On Liquidator In Liquidation Proceedings The Supreme Court recently clarified that the advice provided by the...
Cyril Amarchand Mangaldas Advised Prestige Estates Projects On ₹5,000 Cr QIP Cyril Amarchand Mangaldas Advised Prestige Estates Projects Ltd as its Legal Counsel as to Indian law, on its Qualified...
NCLAT Rules Section 12A Applications Not Permissible During Liquidation Period The National Company Law Appellate Tribunal (NCLAT) Principal Bench, comprising Justice Ashok Bhushan (Chairperson),...
Cyril Amarchand Mangaldas Advised Unicommerce eSolutions And AceVector On Unicommerce eSolutions' ₹2,765.72 Million IPO Cyril Amarchand Mangaldas (CAM) advised Unicommerce eSolutions Limited...
Supreme Court Constitution Bench Begins Hearing On Legality Of PSUs Appointing Arbitrators from Self-Curated Panels On August 28, Constitution Bench of the Supreme Court began hearing a significant...
NCLAT Rules: SARFAESI Act Actions Halted By Interim Moratorium Under IBC The National Company Law Appellate Tribunal (NCLAT), Principal Bench New Delhi, has ruled that once an interim moratorium is...
NCLAT Declares GST Dispute Not A Bar To Section 9 IBC Proceedings The NCLAT Bench, comprising Justice Rakesh Kumar Jain (Member Judicial) and Arun Baroka (Member Technical), has ruled that a dispute...
Cyril Amarchand Mangaldas Advised Akums Drugs And Pharmaceuticals On ₹18,567.37 Million IPO Cyril Amarchand Mangaldas (CAM) advised Akums Drugs and Pharmaceuticals Limited (the Company) as its legal...
NCLAT Rules No Violation Of IBC Section 14(1)(d) In Auction Of Subsidiary Assets The National Company Law Appellate Tribunal (NCLAT), Principal Bench in New Delhi, has determined that there is no...
Cyril Amarchand Mangaldas Advised Akums Drugs & Pharmaceuticals On ₹18,567.37 Million IPO Cyril Amarchand Mangaldas advised Akums Drugs & Pharmaceuticals Ltd (the Company) as their legal...
